Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: PARABON NANOLABS, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-06-17 to 2023-12-16
Current total value of award: $599999
Description: THE OBJECTIVE OF THIS CONTRACT IS TO DEVELOP A DNA-BASED HIV VACCINE THAT WILL STIMULATE PRODUCTION OF BROADLY NEUTRALIZING ANTIBODIES (BNABS) AGAINST HIV-1 ENVELOP PROTEIN (ENV) TRIMER ANTIGENS. EDITED BY CORNORJ_NIH ON 12/10/2021 07:59:54 EDITED